Vanguard Personalized Indexing Management
MENS

Vanguard Personalized Indexing Management’s Jyong Biotech MENS Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio MENS Stock Details MENS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13,927
Closed -$29.9K – 2353
2026
Q1 		$29.9K Buy
+13,927
New +$34.1K ﹤0.01% 2096

Other funds holding MENS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
SOW
State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Personalized Indexing Management's MENS Position: Q2 2026 in Review

Vanguard Personalized Indexing Management sold out of Jyong Biotech (MENS) in Q2 2026, closing a stake of 13,927 shares — an estimated $29.9K sold.

Vanguard Personalized Indexing Management first reported a position in MENS in Q1 2026 and held it in 1 quarter. The position peaked at $29.9K in Q1 2026. 19 funds tracked by Wall St. Rank hold MENS as of Q2 2026.

  • Vanguard Personalized Indexing Management reported no remaining Jyong Biotech position as of Q2 2026 after selling out during the quarter.
  • Vanguard Personalized Indexing Management sold 13,927 Jyong Biotech shares in Q2 2026, an estimated $29.9K.
  • Vanguard Personalized Indexing Management first reported a position in Jyong Biotech in Q1 2026 and held it in 1 quarter.
  • Vanguard Personalized Indexing Management's Jyong Biotech position peaked at $29.9K in Q1 2026.
  • 19 funds tracked by Wall St. Rank held Jyong Biotech as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.